Articles published by Axonics, Inc.
Axonics Reports Third Quarter 2024 Financial Results
November 07, 2024
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics Receives Regulatory Approval for Fourth-Generation Rechargeable SNM System in Australia
September 26, 2024
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics Prevails in Patent Infringement Lawsuit with Medtronic
September 18, 2024
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics Reports Second Quarter 2024 Financial Results
August 01, 2024
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics Reports First Quarter 2024 Financial Results
April 30, 2024
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics Receives CE Mark Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
March 14, 2024
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics Responds to ITC Action by Medtronic
February 29, 2024
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics Reports Fourth Quarter and Fiscal Year 2023 Financial Results
February 28, 2024
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
From Axonics, Inc.
Via Business Wire
Axonics Reports Preliminary 4Q23 and Fiscal Year 2023 Revenue
January 08, 2024
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics to Present at the J.P. Morgan Healthcare Conference
December 27, 2023
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics to Participate in November Investor Conferences
November 01, 2023
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics Reports Third Quarter 2023 Financial Results
October 30, 2023
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics to Report Third Quarter 2023 Financial Results on October 30
October 02, 2023
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics to Participate in September Investor Conferences
August 25, 2023
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics Announces CFO Retirement and Appoints Successor
August 21, 2023
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics Reports Second Quarter 2023 Financial Results
July 27, 2023
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics Reports First Quarter 2023 Financial Results
May 01, 2023
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics to Participate in Upcoming Investor Conferences
April 25, 2023
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics Ranked No. 2 on the Financial Times 2023 List of the Fastest Growing Companies in the Americas
March 29, 2023
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics to Participate in the SUFU 2023 Winter Meeting
March 07, 2023
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics to Report Fourth Quarter 2022 Financial Results on March 1
February 08, 2023
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics Receives FDA Approval for Fourth-Generation Rechargeable Sacral Neuromodulation System
January 31, 2023
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Axonics Reports Preliminary Fiscal Year 2022 Revenue and Provides Fiscal Year 2023 Revenue Guidance
January 11, 2023
From Axonics, Inc.
Via Business Wire
Tickers
AXNX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free